• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Nvidia offers EU concessions over $54 billion Arm deal

October 6, 2021 by David Barret Leave a Comment

October 6, 2021

By Foo Yun Chee

BRUSSELS (Reuters) -Nvidia has offered concessions in a bid to secure EU antitrust approval for its $54 billion acquisition of British chip designer Arm, a European Commission filing showed on Wednesday.

The deal announced by world’s biggest maker of graphics and AI chips last year has sparked concerns in the semiconductor industry over whether Arm could remain a neutral player licensing intellectual property to customers and rivals.

The EU competition enforcer, which did not provide details of the concessions in line with its policy, set an Oct. 27 deadline for its decision.

It will now seek feedback from rivals and customers before deciding whether to accept the concessions, demand more or open a four-month long investigation.

Nvidia has said it would maintain Arm as a neutral technology supplier as it aims to allay concerns from customers such as Qualcomm Inc, Samsung Electronics Co Ltd and Apple Inc.

Arm customers Broadcom, MediaTek and Marvell are supporters of the deal.

Arm, owned by Japan’s SoftBank Group Corp, is a major player in global semiconductors. Its designs power nearly every smartphone and millions of other devices.

(Reporting by Foo Yun Chee; editing by Louise Heavens and Jason Neely)

Source Link Nvidia offers EU concessions over $54 billion Arm deal

David Barret
David Barret

Related posts:

  1. Mexico’s top court decriminalizes abortion in ‘watershed moment’
  2. SoftBank leads $680 million funding round in NFT fantasy soccer game Sorare
  3. Evergrande woes hit Japan’s toilet, air-conditioner and paint manufacturers
  4. ‘No Time to Die’ opens with $121 million in international box office sales

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Common Brain Parasite Infecting Up To 30 Percent Of Americans Disrupts Neuron Communication
  • First Clear Example Of A “Ghost” Mantle Plume Discovered Beneath Arabia
  • “Some People Took JAWS As A License To Kill”: 50 Years On, Can We Turn Fear To Fascination?
  • IFLScience The Big Questions: Would You Rather Go To Space Or The Bottom Of The Sea?
  • Cup Of Water On Tiangong Space Station Sparks Bizarre Conspiracy Theories
  • Simulations Of Early Solar Systems Find Up To 40 Percent Chance That Planet Nine Exists
  • The Last Time NASA’s Voyager “Looked Back” At Our Solar System, This Is What It Saw
  • What Are Those Tiny Dots On Apples?
  • Homo Erectus And Neanderthals May Have Been The First Humans To Do Math
  • Portuguese Man O’ War Found To Be Four Species Not One After 250 Years
  • Revolutionary Drug That’s “Closest Thing” To HIV Vaccine Gets FDA Approval
  • This Is Your Brain On ChatGPT: Lower Neural Interconnectivity And “Soulless” Work
  • In November 2026, A Human-Made Object Will Reach A Light-Day From Earth For First Time In History
  • Alan Turing Masterpieces “Almost Shredded” By Owners Fetch $625,000 At Auction
  • Salton Sea: California’s Largest And Most Polluted Lake Is Even More Toxic Than Thought
  • Sharks Follow A Fundamental Law Of Geometry, And That’s A Really Big Deal
  • “Swarm Intelligence” Sees Longhorn Crazy Ants Clear The Path For Nestmates
  • Cave Remains Reveal Earliest Evidence Of Ice Age Indigenous Australians At High Altitude
  • Scientists Have Finally Identified A Denisovan Skull – It’s Been Hiding In Plain Sight Since 1933
  • Thought Horns Were Just For Cows? This Striking Triple-Horned Chameleon Proves Otherwise
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version